MedPath

Study of the therapeutic effects of magnesium sulfate in patients with acute migraine

Not Applicable
Recruiting
Conditions
Migraine.
Migraine
Registration Number
IRCT20190504043470N1
Lead Sponsor
Vice Chancellor for Research, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Confirmed diagnosis of migraine
Pain scores more than 4

Exclusion Criteria

History of drug adverse reactions
Pregnancy
Lactation
Renal failure

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Headache pain score. Timepoint: 0, 15, 30, 45 minutes after treatment. Method of measurement: VAS questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath